1.
    发明专利
    未知

    公开(公告)号:SE7413303L

    公开(公告)日:1975-04-24

    申请号:SE7413303

    申请日:1974-10-22

    Applicant: ABBOTT LAB

    Abstract: Covers the esters of gamma -glutamyl amide of dopamine selected from the group consisting of -CH2-CH2-NHO ¦ PARALLEL C-CH2-CH2-CH-C-OR PARALLEL ¦ ONH2 where R is a C1-C20 alkyl radical, and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said esters of gamma -glutamyl amide of dopamine to increase renal blood flow by administering said amide to warm-blooded mammals by clinically acceptable routes of administration such as oral, parenteral, rectal, etc.

    5.
    发明专利
    未知

    公开(公告)号:SE7609886L

    公开(公告)日:1977-03-12

    申请号:SE7609886

    申请日:1976-09-07

    Applicant: ABBOTT LAB

    Abstract: This invention covers diacylated derivatives of gamma -glutamyl dopamine selected from the group consisting of where R is a C1-C12 straight or branched chain alkyl radical, a phenyl ring or a substituted phenyl ring and R' is H or a C1-C7 alkyl, and a pharmaceutically acceptable acid addition salt thereof.

    6.
    发明专利
    未知

    公开(公告)号:SE409702B

    公开(公告)日:1979-09-03

    申请号:SE7413303

    申请日:1974-10-22

    Applicant: ABBOTT LAB

    Abstract: Covers the esters of gamma -glutamyl amide of dopamine selected from the group consisting of -CH2-CH2-NHO ¦ PARALLEL C-CH2-CH2-CH-C-OR PARALLEL ¦ ONH2 where R is a C1-C20 alkyl radical, and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said esters of gamma -glutamyl amide of dopamine to increase renal blood flow by administering said amide to warm-blooded mammals by clinically acceptable routes of administration such as oral, parenteral, rectal, etc.

    9.
    发明专利
    未知

    公开(公告)号:DK552074A

    公开(公告)日:1975-07-07

    申请号:DK552074

    申请日:1974-10-22

    Applicant: ABBOTT LAB

    Abstract: Covers the esters of gamma -glutamyl amide of dopamine selected from the group consisting of -CH2-CH2-NHO ¦ PARALLEL C-CH2-CH2-CH-C-OR PARALLEL ¦ ONH2 where R is a C1-C20 alkyl radical, and a pharmaceutically acceptable acid addition salt thereof. Also covers the use of said esters of gamma -glutamyl amide of dopamine to increase renal blood flow by administering said amide to warm-blooded mammals by clinically acceptable routes of administration such as oral, parenteral, rectal, etc.

Patent Agency Ranking